Update on the treatment of small cell lung cancer (SCLC)ARDIZZONI, Andrea; GROSSI, Francesco.Annals of oncology. 2000, Vol 11, pp 101-108, issn 0923-7534, SUP3Conference Paper

Validation of standard definition of sensitive versus refractory relapsed small cell lung cancer: A pooled analysis of topotecan second-line trialsARDIZZONI, Andrea; TISEO, Marcello; BONI, Luca et al.European journal of cancer (1990). 2014, Vol 50, Num 13, pp 2211-2218, issn 0959-8049, 8 p.Article

The role of systemic chemotherapy in the treatment of brain metastases from small-cell lung cancerGROSSI, Francesco; SCOLARO, Tindaro; TIXI, Lucia et al.Critical reviews in oncology/hematology. 2001, Vol 37, Num 1, pp 61-67, issn 1040-8428Article

Prognostic role of hyponatremia in 564 small cell lung cancer patients treated with topotecanTISEO, Marcello; BUTI, Sebastiano; BONI, Luca et al.Lung cancer. 2014, Vol 86, Num 1, pp 91-95, issn 0169-5002, 5 p.Article

Typhlitis during second-line chemotherapy with pemetrexed in non-small cell lung cancer (NSCLC): A case reportTISEO, Marcello; GELSOMINO, Francesco; BARTOLOTTI, Marco et al.Lung cancer. 2009, Vol 65, Num 2, pp 251-253, issn 0169-5002, 3 p.Article

NF-kB activation and p38 phosphorilation in microglial cells infected with Leptospira or exposed to partially purified leptospiral lipoproteinsBLASI, Elisabetta; ARDIZZONI, Andrea; COLOMBARI, Bruna et al.Microbial pathogenesis. 2007, Vol 42, Num 2-3, pp 80-87, issn 0882-4010, 8 p.Article

Enhanced effectiveness of last generation antiblastic compounds vs. cisplatin on malignant pleural mesothelioma cell linesDE CUPIS, Alessandra; SEMINO, Claudia; PIRANI, Paolo et al.European journal of pharmacology. 2003, Vol 473, Num 2-3, pp 83-95, issn 0014-2999, 13 p.Article

Activity and Safety of Dose-Adjusted Infusional Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Chemotherapy With Rituximab in Very Elderly Patients With Poor-Prognostic Untreated Diffuse Large B-Cell Non-Hodgkin LymphomaMUSOLINO, Antonino; BOGGIANI, Daniela; PANEBIANCO, Michele et al.Cancer. 2011, Vol 117, Num 5, pp 964-973, issn 0008-543X, 10 p.Article

Hypertriglyceridaemia with bexarotene in cutaneous T cell lymphoma : the role of omega-3 fatty acidsMUSOLINO, Antonino; PANEBIANCO, Michele; ZENDRI, Enrico et al.British journal of haematology. 2009, Vol 145, Num 1, pp 84-86, issn 0007-1048, 3 p.Article

Predictive and prognostic value of early response assessment using 18FDG-PET in advanced non-small cell lung cancer patients treated with erlotinibTISEO, Marcello; IPPOLITO, Massimo; CAFFARRA, Cristina et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 2, pp 299-307, issn 0344-5704, 9 p.Article

Reliability of EGFR and KRAS mutation analysis on fine-needle aspiration washing in non-small cell lung cancerBOZZETTI, Cecilia; NALDI, Nadia; DE FILIPPO, Massimo et al.Lung cancer. 2013, Vol 80, Num 1, pp 35-38, issn 0169-5002, 4 p.Article

Multifactorial Central Nervous System Recurrence Susceptibility in Patients With HER2-Positive Breast Cancer: Epidemiological and Clinical Data From a Population-Based Cancer Registry StudyMUSOLINO, Antonino; CICCOLALLO, Laura; PANEBIANCO, Michele et al.Cancer. 2011, Vol 117, Num 9, pp 1837-1846, issn 0008-543X, 10 p.Article

Influence of hyaluronic acid on bacterial and fungal species, including clinically relevant opportunistic pathogensARDIZZONI, Andrea; NEGLIA, Rachele G; BASCHIERI, Maria C et al.Journal of materials science. Materials in medicine. 2011, Vol 22, Num 10, pp 2329-2338, issn 0957-4530, 10 p.Article

Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu-Positive Metastatic Breast CancerMUSOLINO, Antonino; NALDI, Nadia; NERI, Tauro Maria et al.Journal of clinical oncology. 2008, Vol 26, Num 11, pp 1789-1796, issn 0732-183X, 8 p.Article

Pemetrexed Versus Pemetrexed and Carboplatin As Second-Line Chemotherapy in Advanced Non―Small―Cell Lung Cancer: Results of the GOIRC 02-2006 Randomized Phase II Study and Pooled Analysis With the NVALT7 TrialARDIZZONI, Andrea; TISEO, Marcello; BONI, Corrado et al.Journal of clinical oncology. 2012, Vol 30, Num 36, pp 4501-4507, issn 0732-183X, 7 p.Article

An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC) : Data report from ItalyTISEO, Marcello; GRIDELLI, Cesare; BELVEDERE, Ornella et al.Lung cancer. 2009, Vol 64, Num 2, pp 199-206, issn 0169-5002, 8 p.Article

Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell linesLA MONICA, Silvia; GALETTI, Maricla; FUMAROLA, Claudia et al.Biochemical pharmacology. 2009, Vol 78, Num 5, pp 460-468, issn 0006-2952, 9 p.Article

Cisplatin-versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer : An individual patient data meta-analysisARDIZZONI, Andrea; BONI, Luca; BISSET, Donald et al.Journal of the National Cancer Institute. 2007, Vol 99, Num 11, pp 847-857, issn 0027-8874, 11 p.Article

A breast cancer patient from Italy with germline mutations in both the BRCA1 and BRCA2 genesMUSOLINO, Antonino; NALDI, Nadia; MICHIARA, Maria et al.Breast cancer research and treatment. 2005, Vol 91, Num 2, pp 203-205, issn 0167-6806, 3 p.Article

Lomustine (chloroethyinitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-hodgkin lymphomaMUSOLINO, Antonino; PERRONE, Maria Antonietta; MICHIARA, Maria et al.Cancer. 2005, Vol 103, Num 10, pp 2109-2117, issn 0008-543X, 9 p.Article

Treatment of advanced non-small-cell lung cancer in the elderly: Results of an International Expert PanelGRIDELLI, Cesare; AAPRO, Matti; SHEPHERD, Frances et al.Journal of clinical oncology. 2005, Vol 23, Num 13, pp 3125-3137, issn 0732-183X, 13 p.Article

Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: A prospective European Organization for Research and Treatment of Cancer-Lung Cancer Group Phase III Trial-08923ARDIZZONI, Andrea; TJAN-HEIJNEN, Vivianne C. G; LEGRAND, Catherine et al.Journal of clinical oncology. 2002, Vol 20, Num 19, pp 3947-3955, issn 0732-183X, 9 p.Article

Second Italian Consensus Conference on Malignant Pleural Mesothelioma: State of the art and recommendationsPINTO, Carmine; NOVELLO, Silvia; MIRABELLI, Dario et al.Cancer treatment reviews. 2013, Vol 39, Num 4, pp 328-339, issn 0305-7372, 12 p.Article

Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic OncologyGRIDELLI, Cesare; ARDIZZONI, Andrea; DI MAIOF, Massimo et al.Lung cancer. 2010, Vol 68, Num 3, pp 319-331, issn 0169-5002, 13 p.Article

Predictive and Prognostic Significance of Neuron-specific Enolase (NSE) in Non-small Cell Lung CancerTISEO, Marcello; ARDIZZONI, Andrea; ARGENIDE CAFFERATA, Mara et al.Anticancer research. 2008, Vol 28, Num 1B, pp 507-513, issn 0250-7005, 7 p.Article